Ailomics Therapeutics
Ailomics Therapeutics is a pharmaceutical R&D startup that utilizes a pioneering computational and experimental platform to discover novel targets and develop first-in-class therapeutics for diseases with significant unmet medical needs. The company leverages patient-derived omics data and AI-augmented bioinformatics analytics to understand disease biology and identify progression-driving targets. Ailomics develops high-translatability disease models for validating targets and screening functional molecules for therapeutic interventions, while also discovering predictive biomarkers and developing companion diagnostics for patient stratification in clinical trials. Their business model includes internal R&D, co-development of therapeutics with pharmaceutical MNCs, and companion diagnostics with IVD companies.
Ailomics Therapeutics
Ailomics Therapeutics is a pharmaceutical R&D startup that utilizes a pioneering computational and experimental platform to discover novel targets and develop first-in-class therapeutics for diseases with significant unmet medical needs. The company leverages patient-derived omics data and AI-augmented bioinformatics analytics to understand disease biology and identify progression-driving targets. Ailomics develops high-translatability disease models for validating targets and screening functional molecules for therapeutic interventions, while also discovering predictive biomarkers and developing companion diagnostics for patient stratification in clinical trials. Their business model includes internal R&D, co-development of therapeutics with pharmaceutical MNCs, and companion diagnostics with IVD companies.